Featured Research

from universities, journals, and other organizations

Slimy Bacteria Common Cause Of Chronic Infections

Date:
May 24, 1999
Source:
Montana State University
Summary:
Bacterial slime is the culprit behind many nagging infections that plague children and adults, say scientists from Montana State University-Bozeman and the University of Iowa in a paper published May 21, 1999 in the journal Science.

BOZEMAN, MT--Bacterial slime is the culprit behind many nagging infections that plague children and adults, say scientists from Montana State University-Bozeman and the University of Iowa in a paper published May 21, 1999 in the journal Science.

Ear infections, periodontitis and cystic fibrosis pneumonia are just a few examples of the infections that involve sticky communities of bacteria called biofilms. Lingering infections can also occur when a person has sutures, contact lenses, urinary catheters, intrauterine devices (IUDs), mechanical heart valves, penile prostheses, and a variety of other implanted devices or procedures.

The researchers explain the relationship between biofilms and infections in a review paper titled, "Bacterial Biofilms: A Common Cause of Persistent Infections." William Costerton, director of MSU's Center for Biofilm Engineering (CBE), is the lead author. Co-authors are Philip Stewart of the CBE and Pete Greenberg of the University of Iowa.

"We have made mild inroads into the medical area since '92," Costerton said. "We are chipping away at our image of bacteria."

Recent advances in understanding the genetic and molecular makeup of biofilms may help find ways to control related infections, the article says.

Science is a weekly journal that publishes scientific news, as well as the most significant breakthroughs in global research. It is the world's largest circulation journal for a general science audience.

"Having a paper accepted that you submitted is rare," Costerton commented. "But then to be invited to write a review for them is a world recognition. I think it's wonderful."

Science is an ideal forum since it covers the "whole spectrum of science, medicine and engineering," he added.

The biofilm article reviews much of the work that has become familiar to followers of the CBE. It tells how bacteria attach to surfaces and, when there's a quorum of cells, form biofilms. It explains the communication that goes on between cells as they create microscopic communities complete with canals, towers and even balloons. It describes how bacteria know when to come together and when to disperse.

The paper goes on to discuss the environmental and medical problems that can result from biofilms. Cystic fibrosis is about the best example of a persistent infection that involves slime, said Costerton, who has seen it close-up for more than 30 years. Costerton and Greenberg each have a child with cystic fibrosis, a disorder that produces abnormally thick mucus in the lungs.

The Science article also explains why it's so difficult to fight biofilm infections. Biofilms, for a variety of reasons, resist the antibiotic artillery that's lodged against them. One theory is that some of the cells grow so slowly - or are so starved - that they don't pass along the antibiotics. Another idea is that some of the cells set up barriers to block penetration.

The future of biofilm research will see the continued dissection of biofilms on a molecular and genetic level, the article says.

"Our modern view of biofilm infections leads to the realization that their effective control will require a concerted effort to develop therapeutic agents that target the biofilm phenotype and community signaling based agents that prevent the formation, or promote the detachment, of biofilms," the article concludes. The techniques are now available to undertake such efforts.


Story Source:

The above story is based on materials provided by Montana State University. Note: Materials may be edited for content and length.


Cite This Page:

Montana State University. "Slimy Bacteria Common Cause Of Chronic Infections." ScienceDaily. ScienceDaily, 24 May 1999. <www.sciencedaily.com/releases/1999/05/990524040309.htm>.
Montana State University. (1999, May 24). Slimy Bacteria Common Cause Of Chronic Infections. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1999/05/990524040309.htm
Montana State University. "Slimy Bacteria Common Cause Of Chronic Infections." ScienceDaily. www.sciencedaily.com/releases/1999/05/990524040309.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins